1Chen JM, Levin HR, Michler RE, et al. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg, 1997, 114(4):627-634.
2Weston MW, Isaac BF, Crain C. The use of inhaled prostacyelin in nitroprusside resistant pulmonary artery hypertension. J Heart Lung Transplant, 2001,20(12) : 1340-1344.
3Klotz S, Deng MC, Hanafy D, et al. Reversible pulmonary hypertension in heart transplant candidates-pretransplant evalualion and outcome after orthotopic heart transplantation. Eur J Heart Fail, 2003,5(5) :645-653.
4Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol, 1992,19(1):48-54.
5Delgado JF, GOmez Scinchez MA, Saenz de la Calzada C, et al. Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. J Heart Lung Transplant, 2001,20 (9) : 942-948.
6Butler J, Stankewicz MA, Wu J, et al. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J Heart Lung Transplant, 2005,24(2): 170 177.
7Klotz S, Wenzelburger pulmonary hypertension Stypmann J, et heart transplant al. Reversible candidates, to transplant or not to transplant. Ann Thorac Surg, 2006,82(5) 1770-1773.
8Drakos SG, Kfoury AG, Gilbert EM, et al. Effect of reversible pulmonary hypertension on outcomes after heart transplantation. J Heart Lung Transplant, 2007,26(4):319-323.
9Goland S, Czer LS, Kass RM, et al. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemoclynamic follow up after orthotopic heart transplantation. J Heart Lung Transplant, 2007,26 (4):312-318.
10Braun S, Schrotter H, Schmeisser A, et al. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension. Int J Cardiol,2007,115(1): 67-72.
